|
|
||||||||
1 Biochemisches Institut der Universität Zürich, CH-8057 Zürich, Switzerland
2 Architecture et Fonction des Macromolécules Biologiques, UPR 9039-CNRS, F-13402 Marseille Cedex 20, France
(RECEIVED April 17, 2005; FINAL REVISION July 15, 2005; ACCEPTED July 20, 2005)
The structure of the scFv fragment FITC-E2, obtained from a naive phage antibody scFv library derived from human donors, was determined at 2.1 Å resolution in the free form and at 3.0 Å in the complexed form. The wild-type (wt) scFv binds fluorescein with a KD of 0.75 nM. The free scFv readily crystallizes by compacting its 18 amino acid-long CDR-H3, partially occluding the binding site and further blocking access by binding to the "bottom" of a neighboring scFv molecule with a cluster of exposed aromatic residues within CDR-H3. Only upon mutating one of the residues involved in this dominant crystal contact, an exposed tryptophan in the middle of CDR-H3, crystals of the complex could be obtained. A series of alanine mutants within the putative antigen binding site, covering a range of binding affinities, were used to relate macroscopic thermodynamic and kinetic binding parameters to single-molecule disruption forces measured by AFM. The effects of the mutations on the binding properties, particularly on the fraction of binding-competent molecules within the population, cannot be fully explained by changes in the strength of local interactions. The significant conformational change of CDR-H3 between the free and the liganded form illustrates the plasticity of the binding site. An accompanying study in this issue by Curcio and colleagues presents the molecular dynamics simulation of the forced unbinding experiments and explores possible effects of the mutations on the unbinding pathway of the hapten.
Keywords: structure/function studies; proteins of the immune system; active site; binding site; epitope mapping; crystallography; protein crystallization; forces and stability; mutagenesis (site-directed and general); atomic force microscopy
Abbreviations: VH, variable domain of antibody heavy chain VL, variable domain of antibody light chain scFv, single-chain variable fragment of an antibody FITC, fluorescein isothiocyanate BSA, bovine serum albumin wt, wild-type AFM, atomic force microscopy CDR, complementarity determining region of an antibody ORE, Oregon Green 488 PDB, Protein Data Bank
Article and publication are at http://www.proteinscience.org/cgi/doi/10.1110/ps.051520605.
Reprint requests to: Andreas Plückthun, Biochemisches Institut der Universität Zürich, Winterthurerstrasse 190, CH-8057 Zürich, Switzerland; e-mail: plueckthun{at}bioc.unizh.ch; fax: 41-44-635-5712.
![]()
CiteULike
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
R. Curcio, A. Caflisch, and E. Paci Change of the unbinding mechanism upon a mutation: A molecular dynamics study of an antibody-hapten complex Protein Sci., October 1, 2005; 14(10): 2499 - 2514. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |